Last $158.99 USD
Change Today -4.69 / -2.87%
Volume 1.4M
ALXN On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/31/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Larry L. Mathis

Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee, Alexion Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 2 different organizations across 3 different industries.

See Board Relationships
70$450,635

Background*

Mr. Larry L. Mathis served as the Chief Executive Officer of The Methodist Health Care System in Houston, Texas since 1983. From 1997 to 1998, Mr. Mathis served as a consultant to the Chairman of the System of The Methodist Health Care System, in Houston, Texas. Mr. Mathis was President and Chief Executive Officer, as well as a member of the Board of Directors from 1983 to 1997. He served many leadership positions in organizations charged with planning and directing ...

Read Full Background

Corporate Headquarters*

352 Knotter Drive
Cheshire, Connecticut 06410

United States

Phone: 203-272-2596
Fax: 203-271-8198

Board Members Memberships*

Former Director
Director for Healthcare Trust of America Inc
1997-2003
Former Director
2004-2014
Former Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee
2007-Present
Independent Director, Chairman of Risk Management Committee, Member of Nominating & Corporate Governance Committee and Member of Audit Committee

Education*

MA
Washington University, St. Louis
BA
Pittsburg State University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$105,000
Total Calculated Compensation$450,635
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ALXN:US $158.99 USD -4.69

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Leonard S. Schleifer M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee
Regeneron Pharmaceuticals, Inc.
$3.1M
Martine A. Rothblatt Ph.D., J.D., MBAFounder, Chairman and Chief Executive Officer
United Therapeutics Corporation
$992.7K
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.0M
Simon E. Moroney Ph.D.Chairman of Management Board and Chief Executive Officer
Morphosys AG
€772.6K
Randal J. Kirk J.D.Chairman, Chief Executive Officer and President
Intrexon Corporation
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALEXION PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.